Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Allarity Therapeutics, Inc.

NASDAQ: ALLR · Life Sciences · 8 alerts · CIK 1860657

Share price
$0.8752Close, Nov 16
Market cap
$14M
Shares outstanding
16MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Allarity Therapeutics, Inc. filings on SEC EDGAR ↗

8:00 AM ET 8-K
Business Update

Allarity Therapeutics Business Update

Allarity Therapeutics provided an operational update regarding its proprietary Drug Response Predictor (DRP) technology, patent portfolio, and in-house laboratory capabilities. The company highlighted that higher DRP scores were associated with longer overall survival in ovarian cancer patients treated with stenoparib, supporting its strategy to use the technology for patient selection in upcoming pivotal trials.

8:01 AM ET 8-K
Business Update

Allarity Therapeutics Business Update

Allarity Therapeutics has expanded its in-house medical laboratory capabilities to include proteomics and cell line research. These new capabilities will support deeper mechanism-of-action research for its lead asset, stenoparib, and allow the company to offer a broader range of research services to external partners. The expansion is expected to create cost efficiencies without impacting the company's current cash runway.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.